AbelZeta Pharma

AbelZeta Pharma is a global clinical-stage cell therapy company discovering, developing, and manufacturing T-cell-based immunotherapeutics for cancer and immunological diseases. Its pipeline centers on Chimeric Antigen Receptor (CAR)-T cell technology across hematologic malignancies, solid tumors, and inflammatory and immunological conditions. Backed by Hongshan (formerly Sequoia Capital China), AbelZeta develops personalized immune cell therapies that empower patients' own immune systems to address unmet medical needs, with operations in the United States (Maryland) and China. AbelZeta does not currently publish a public developer API; this profile captures the company's corporate web presence and identity within the API Evangelist network.

AbelZeta Pharma is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biotechnology, Cell Therapy, and Immunotherapy.

AbelZeta Pharma’s developer surface includes engineering blog, support, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

15.0/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyHealthcareBiotechnologyCell TherapyImmunotherapyCAR-TPharmaceuticalsOncology

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 15.0/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/abelzeta-pharma: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: abelzeta-pharma
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/abelzeta-pharma.png
name: AbelZeta Pharma
description: AbelZeta Pharma is a global clinical-stage cell therapy company discovering, developing, and manufacturing T-cell-based
  immunotherapeutics for cancer and immunological diseases. Its pipeline centers on Chimeric Antigen Receptor (CAR)-T cell
  technology across hematologic malignancies, solid tumors, and inflammatory and immunological conditions. Backed by Hongshan
  (formerly Sequoia Capital China), AbelZeta develops personalized immune cell therapies that empower patients' own immune
  systems to address unmet medical needs, with operations in the United States (Maryland) and China. AbelZeta does not currently
  publish a public developer API; this profile captures the company's corporate web presence and identity within the API Evangelist
  network.
url: https://raw.githubusercontent.com/api-evangelist/abelzeta-pharma/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- hongshan
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Healthcare
- Biotechnology
- Cell Therapy
- Immunotherapy
- CAR-T
- Pharmaceuticals
- Oncology
apis: []
common:
- type: DomainSecurity
  url: security/abelzeta-pharma-domain-security.yml
- type: Website
  url: https://www.abelzeta.com/
- type: Blog
  url: https://www.abelzeta.com/newsroom/
- type: Support
  url: https://www.abelzeta.com/contact/
- type: PrivacyPolicy
  url: https://www.abelzeta.com/privacy-policy/
- type: TermsOfService
  url: https://www.abelzeta.com/terms-and-conditions/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence